Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Think we're getting ready for an inflated placing
completely forgot this former share until it got highlighted by the rise. funnier someone references Woodie. NO it is a former winnifrith share which went the same way as ALL his other "tips". if that is the right word cos he is essentially a paid ramper of his pals` garbage, ruining many lives in the process I think. his cover is endlessly digging at Woodie, while simply ignoring his damaging picks. constant reminders neede about him while he has his site to mislead newbies.
As a LTH over +years Ive needed to adjust my mindset. The fiasco of China ... needs to be put to one side and this now treated as a business and product that only launched last Nov in the UK. I know I sound like a broken record but ive seen us at highs of 24p and endless promises, but as I said this needs to be parked. I have averaged down a lot as I really do believe in this product. We have made the right moves with Boots, Amazon and he recent partnership announcement. Our scale and reach to advertise has always troubled me, but Fertility Clinics and the NHS could be the answer here. Have not sold a bean over the past 3+ years and don't intend to. Agree with the thoughts around this could be 12 or 24 months slow burner now, but do believe this has staggering potential for returns. IMHO. Good luck all and keep the faith LTHs
Where did this spoof move of 20% come from. There has been no commercial sales updates and no one in their right frame of mind would be buying as the next announcement will likely bring on more dilution.
Concepta was founded by Michael Catt and Zhang Zhi Gang, both previously worked for Unipath/Unilever and were involved in the development of the Clearblue ovulation product, a market leader for 20 years. This was was a big innovation in OTC diagnostics at the time… Take a look at https://patents.google.com/patent/US6403380. Clearblue was sold by Unilever to Inverness Medical/ALERE (now Abbott) in 2001 for 116 million euro. Concepta offer an advance over the Clearblue product and in my opinion represents a similar opportunity to sell to one of the majors once the performance is demonstrated. Whether is in in 12, 24 months or longer its value should be significantly greater than the current share price....
https://www.mirror.co.uk/tech/womens-femtech-health-gadgets-including-20374814
Long term lurker. Know enough about the Life Science, Healthcare and Consumer Health space to make me dangerous.
I am confident the share price will see a turnaround. There is still a lot to be done and a fair way to go, but the Board and Chairman combined with a very sound technology offering with a strong clinical and consumer utility, gives me a great deal of confidence. I know the fertility and diagnostic market well.
I believe these recent lows are a floor and we should see a steady creep in price in the right direction. As said, plenty still to do, but headed in the right direction. Top line sales will come, that is for sure.
Does Woodford holds this share? If so explains the drop.
It’s a sad reflection of how this share moves ... down 20% then up on no news. Personally I won’t get excited until we are back over 5p ... switching off until then ... if it ever happens that is. Still believe in this product
23% rise and not one comment. Shows the lack of interest in this. What an investment..
Long term holder, first time poster. What a shame the share price is languishing where it is. It takes a long time for new technology to enter a market, particularly so in the consumer market where a customer won't necessarily understand the benefit or difference compared to the other longer established products and brands that sit along side it... My guess is the BOD will see this and will be looking for a different way to commercialise...
have to think this is going under now.
placing after placing , no real sales to be shouted from the roof tops , no pr , no nothing
Placing on way. Think this is turning into a dead duck..
the sad fact is that for the 6 months to June 30th 2019 we sold c50 units (based on £300 each and total revenue of £15k).
It was available via DTC for whole of this period and also had 3 months in Boots (I think).
I agree getting into fertility clinics is a shrewd move but disagree that CPT can't do advertising. With a limited budget you need to be creative - online via google etc can be very cost effect. We are targeting specific people, those who want to get pregnant and those people will spend money to do so. We don't need a national TV campaign
Similarly CPT could employ a distributor to sell into other regions - yes money will be less but surely MyLotus has a decent gross profit margin to allow a big cut to a distributor and clearly any additional sales are better than none.
At the moment it just looks like 'death by a thousand cuts' and surely CPT will run out of money some day soon.
Yes, i understand.
No doubt we've all experienced similar at some point.
Hope you eventually achieve a return on the investment.
Some of us remember a SP of 20p .... so you understand the frustration!
Interesting. Thanks
Also, yes, i agree about your "Matt knowing about sales" comment.
After more research earlier this evening i gained clarity on his experience.
I can appreciate that many investors are holding a loss. Easy for me to come along and see potential having not experienced the dilution and share price drop.
I find it difficult to ignore the product and the willingness of a Asset Management firm who specialie in bio science and life sciene investment to add a further £750k near to the closing point of H1.
No guarantees, but i've backed what i see as superior knowledge to me from people closer to the detail in regard to a product with widespread potential.
As always, we'll see in time to come.
What does Peter Dines know that we don't?
Answer - a lot.
I'm sure he also has a lot more long term vision than most people here seem to have. It seems people were expecting huge sales figures and a profit in the bank already. I think people need to reset there expectations of a company essentially starting from scratch again after the shambles left by Mr Henau. Then you have people commenting that Matthew doesn't know sales!! What you mean apart from an agreement with a global pharmacy group in WBA which has given the my lotus product a fantastic foothold in the UK market and which will allow Matthew to move the product seamlessly into Europe and most likely America aswell and open up the product to a huge market, because from the talk in the latest RNS their is no doubt in my mind that this move will have all been pre-organised when the deal with boots was agreed and i'm confident that a European sales agreement will be announced in the not too distant future. Additionally getting an agreement with one of the most prominent fertility clinics in the UK which will pave the way for agreements with other such fertility clinics was a very shrewd move aswell, so im not really sure i can agree that Matthew doesnt know sales. This product is brand new its quite obvious that it will take time to build brand and company awareness unless your advertising on a regular basis on mainstream media, TV, national newspapers etc etc all of which would cost millions of pounds, money which Concepta simply doesn't have. This will take a bit of time to get going but from where im standing Matthew is doing exactly what he has promised and their is only one way that sales are going to go from here and the current share price presents a fantastic buying opportunity.
What does Peter Dines know that we don't?
Or, is he a complete and utter fool? :)
Peter Dines: Chief Operating Officer at Mercia and a non-executive director of Concepta
https://www.mercia.co.uk/people-and-culture/people/peter-dines/
April 8th
Mercia (guided by Peter Dines) participated in the Concepta share placing @ £750k
Rather than just participate sufficiently to protect Mercia's share holding percentage from dilution, Mercia go much further and increase their holding in Concepta (18.2% before placing to 22.4% after placing).
May 14th
With only 40 days of H1 remaining and knowing that H1 sales will be light he writes:
"Peter Dines, Chief Operating Officer at Mercia and a non-executive director of Concepta, said: "These first pregnancies and strong testimonials from myLotus® users are hugely exciting. Concepta has made significant commercial progress since launching six months ago and we look forward to further collaborative partnerships increasing the availability of myLotus® across the UK and overseas."
So, Mercia - knowing Concepta's sales data - not only participated in placing but significantly extended their holding.
Are they building a position for the future OR utterly useless at asset management?
Jury is out. Time will tell.
Just from my research i notice they've taken a stand at the forthcoming Fertility Show
https://www.fertilityshow.co.uk/london/visiting/exhibitor-list/P48
Hmm... what to say? All efforts should be about channel sales. I can't see any point moving into Europe etc until you've developed UK. If there's a profitable market then do it on your doorstep first.
In their favour is:
Mercia seem to be onside, the directors recently bought shares, the product appears to be A1, and the Exec Chairman seems to know his onions (but not sales).
I've taken a small position this afternoon. But, if they don't push the product then time will suffocate them.
I don't know what to think anymore ... SP now at a record low even with Boots on board (sort of as online only) ... The new CEO talks a good game ... but his job is to drive value for the company and shareholders, not much evidence of this so far. I still believe in the product but it's all very painful to watch right now
Heard CEO being interviewed today.
Spent the last 20 minutes reviewing the balance sheet.
Where is the drive towards sales growth? Am i missing something?
If that's true then this share and company is an embarrassment ... I'm tied in now so just hoping things change. So much promise with what appears to be a proven ground breaking product
According to this article, Concepta have generated £15,717 from sales of the MyLotus unit. If you average the selling price at £250, then that means they've sold approx 60 units. Maybe fewer if the cost of the consumables (sticks) is part of that number.
http://www.morningstar.co.uk/uk/news/AN_1569839807471804000/concepta-interim-loss-cut;-partners-with-manchester-fertility-clinic.aspx
I can't believe how bad the marketing is for this product, it really doesn't take much to promote the benefits across social media. The Manchester fertility clinic is obviously good news but the lack of marketing is resulting in customers not knowing that this product exists and is readily available in boots/amazon. What has to be atrocious sales volumes is evidence they need to step up the game with product awareness. i worry that this fantastic product won't fulfil its potential.